Danaher (DHR) Total Non-Current Liabilities (2009 - 2026)
Danaher (DHR) posted quarterly Total Non-Current Liabilities of $25.0 billion for Q1 2026, up 10.64% year-over-year from $22.6 billion in Q1 2025, and down 0.77% on a QoQ basis from $25.2 billion in Q4 2025.
Danaher (DHR) Total Non-Current Liabilities (2009 - 2026) Analysis & Trends
Danaher (DHR) has reported Total Non-Current Liabilities for 18 consecutive years, with $25.0 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 10.64% year-over-year to $25.0 billion; the TTM figure through Mar 2026 stood at $25.0 billion (up 10.64% YoY), while the FY2025 annual figure was $25.2 billion, down 66.4% from the prior year.
- Total Non-Current Liabilities came in at $25.0 billion for Q1 2026 at Danaher, down from $25.2 billion in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $80.7 billion in Q4 2022, with the low at $22.6 billion in Q1 2025.
- Average Total Non-Current Liabilities over 5 years is $47.0 billion, with a median of $35.7 billion recorded in 2024.
- Across the five-year window, Total Non-Current Liabilities plunged 69.05% in 2023 and surged 200.49% in 2024, its largest moves.
- Year by year, Total Non-Current Liabilities stood at $80.7 billion in 2022, then slumped by 69.05% to $25.0 billion in 2023, then soared by 200.49% to $75.1 billion in 2024, then slumped by 66.4% to $25.2 billion in 2025, then retreated by 0.77% to $25.0 billion in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $25.0 billion, $25.2 billion, and $23.2 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 737.18 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 5.45 Bn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Quest Diagnostics | 23.76 Bn | 23.67 Bn | 942.00 Mn | 7.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 27, 2026 | 25.03 Bn |
| Dec 31, 2025 | 25.22 Bn |
| Sep 26, 2025 | 23.17 Bn |
| Jun 27, 2025 | 76.28 Bn |
| Mar 28, 2025 | 22.62 Bn |
| Dec 31, 2024 | 75.07 Bn |
| Sep 27, 2024 | 23.66 Bn |
| Jun 28, 2024 | 72.91 Bn |
| Mar 29, 2024 | 35.68 Bn |
| Dec 31, 2023 | 24.98 Bn |
| Sep 29, 2023 | 28.88 Bn |
| Jun 30, 2023 | 78.40 Bn |
| Mar 31, 2023 | 66.35 Bn |
| Dec 31, 2022 | 80.72 Bn |
| Sep 30, 2022 | 26.54 Bn |
| Jul 1, 2022 | 38.40 Bn |
| Apr 1, 2022 | 75.67 Bn |
| Dec 31, 2021 | 77.32 Bn |
| Oct 1, 2021 | 30.85 Bn |
| Jul 2, 2021 | 60.10 Bn |